L. Koman to Cerebral Palsy
This is a "connection" page, showing publications L. Koman has written about Cerebral Palsy.
Connection Strength
4.684
-
Koman LA, Smith BP, Williams R, Richardson R, Naughton M, Griffin L, Evans P. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin. J Hand Surg Am. 2013 Mar; 38(3):435-46.e1.
Score: 0.436
-
Koman LA, Sarlikiotis T, Smith BP. Surgery of the upper extremity in cerebral palsy. Orthop Clin North Am. 2010 Oct; 41(4):519-29.
Score: 0.368
-
Koman LA, Williams RM, Evans PJ, Richardson R, Naughton MJ, Passmore L, Smith BP. Quantification of upper extremity function and range of motion in children with cerebral palsy. Dev Med Child Neurol. 2008 Dec; 50(12):910-7.
Score: 0.320
-
Norris JA, Cabrera MN, Smith TL, Reeves SH, Koman LA. Quantifying spasticity in a clinical setting. Biomed Sci Instrum. 2007; 43:284-9.
Score: 0.284
-
Koman LA, Smith BP, Shilt JS. Cerebral palsy. Lancet. 2004 May 15; 363(9421):1619-31.
Score: 0.237
-
Balkrishnan R, Manuel JC, Smith BP, Camacho FT, Koman LA. Longitudinal examination of health outcomes associated with botulinum toxin use in children with cerebral palsy. J Surg Orthop Adv. 2004; 13(2):76-80.
Score: 0.231
-
Manuel JC, Balkrishnan R, Camacho F, Smith BP, Koman LA. Factors associated with self-esteem in pre-adolescents and adolescents with cerebral palsy. J Adolesc Health. 2003 Jun; 32(6):456-8.
Score: 0.222
-
Manuel J, Naughton MJ, Balkrishnan R, Paterson Smith B, Koman LA. Stress and adaptation in mothers of children with cerebral palsy. J Pediatr Psychol. 2003 Apr-May; 28(3):197-201.
Score: 0.219
-
Koman LA, Paterson Smith B, Balkrishnan R. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin. Paediatr Drugs. 2003; 5(1):11-23.
Score: 0.215
-
Koman LA, Smith BP, Barron R. Recurrence of equinus foot deformity in cerebral palsy patients following surgery: a review. J South Orthop Assoc. 2003; 12(3):125-33, quiz 134.
Score: 0.215
-
Willenborg MJ, Shilt JS, Smith BP, Estrada RL, Castle JA, Koman LA. Technique for iliopsoas ultrasound-guided active electromyography-directed botulinum a toxin injection in cerebral palsy. J Pediatr Orthop. 2002 Mar-Apr; 22(2):165-8.
Score: 0.203
-
Balkrishnan R, Naughton M, Smith BP, Manuel J, Koman LA. Parent caregiver-related predictors of health care service utilization by children with cerebral palsy enrolled in Medicaid. J Pediatr Health Care. 2002 Mar-Apr; 16(2):73-8.
Score: 0.203
-
Koman LA. Cerebral palsy: past, present, and future. J South Orthop Assoc. 2002; 11(2):93-101.
Score: 0.201
-
Koman LA, Brashear A, Rosenfeld S, Chambers H, Russman B, Rang M, Root L, Ferrari E, Garcia de Yebenes Prous J, Smith BP, Turkel C, Walcott JM, Molloy PT. Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. Pediatrics. 2001 Nov; 108(5):1062-71.
Score: 0.199
-
Koman LA, Mooney JF, Smith BP, Walker F, Leon JM. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group. J Pediatr Orthop. 2000 Jan-Feb; 20(1):108-15.
Score: 0.175
-
Koman LA, Mooney JF, Smith BP. Neuromuscular blockade in the management of cerebral palsy. J Child Neurol. 1996 Nov; 11 Suppl 1:S23-8.
Score: 0.140
-
Koman LA, Mooney JF, Smith BP, Goodman A, Mulvaney T. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J Pediatr Orthop. 1994 May-Jun; 14(3):299-303.
Score: 0.118
-
Koman LA, Mooney JF, Smith B, Goodman A, Mulvaney T. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop. 1993 Jul-Aug; 13(4):489-95.
Score: 0.111
-
Koman LA, Mooney JF, Goodman A. Management of valgus hindfoot deformity in pediatric cerebral palsy patients by medial displacement osteotomy. J Pediatr Orthop. 1993 Mar-Apr; 13(2):180-3.
Score: 0.109
-
Kesar TM, Sawaki L, Burdette JH, Cabrera MN, Kolaski K, Smith BP, O'Shea TM, Koman LA, Wittenberg GF. Motor cortical functional geometry in cerebral palsy and its relationship to disability. Clin Neurophysiol. 2012 Jul; 123(7):1383-90.
Score: 0.100
-
Koman LA, Gelberman RH, Toby EB, Poehling GG. Cerebral palsy. Management of the upper extremity. Clin Orthop Relat Res. 1990 Apr; (253):62-74.
Score: 0.089
-
Seyler TM, Smith BP, Marker DR, Ma J, Shen J, Smith TL, Mont MA, Kolaski K, Koman LA. Botulinum neurotoxin as a therapeutic modality in orthopaedic surgery: more than twenty years of experience. J Bone Joint Surg Am. 2008 Nov; 90 Suppl 4:133-45.
Score: 0.081
-
Kolaski K, Ajizian SJ, Passmore L, Pasutharnchat N, Koman LA, Smith BP. Safety profile of multilevel chemical denervation procedures using phenol or botulinum toxin or both in a pediatric population. Am J Phys Med Rehabil. 2008 Jul; 87(7):556-66.
Score: 0.079
-
Mooney JF, Koman LA, Smith BP. Pharmacologic management of spasticity in cerebral palsy. J Pediatr Orthop. 2003 Sep-Oct; 23(5):679-86.
Score: 0.056
-
Balkrishnan R, Camacho FT, Smith BP, Shilt JS, Jacks LK, Koman LA, Rascati KL, Mooney JF. Cost impact of botulinum toxin use in Medicaid-enrolled children with cerebral palsy. J South Orthop Assoc. 2002; 11(2):71-9.
Score: 0.050
-
Goldner JL, Koman LA, Gelberman R, Levin S, Goldner RD. Arthrodesis of the metacarpophalangeal joint of the thumb in children and adults. Adjunctive treatment of thumb-in-palm deformity in cerebral palsy. Clin Orthop Relat Res. 1990 Apr; (253):75-89.
Score: 0.022